ProBioGen is an international biotechnology company based in Berlin-Weißensee, specialising in the development and manufacture of biopharmaceuticals and vaccines. Every day, 300 employees contribute through their creative and meticulous work to advance new therapies and establish innovations worldwide.
Through our research, we support the development of effective and safe medicines – for example, for the treatment of cancer and other serious diseases.
As a partner in the Berlin Center for Gene and Cell Therapies (BC GCT), we are also actively shaping the future of gene and cell therapies and the expansion of state-of-the-art GMP production facilities in Berlin.
Due to continued growth and investment strategy, we are expanding our viral vector capabilities and seeking an experienced leader to build and drive a new Viral Vector Operations unit.
ProBioGen AG is a Berlin-based biotech company specializing in complex therapeutic proteins and viral vector technologies. With strong expertise in cell line development, process development, and GMP manufacturing, we support international biopharma partners in advancing innovative therapies.
